BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25827233)

  • 21. Novel mutations in Thai patients with glanzmann thrombasthenia.
    Ittiwut R; Suchartlikitwong P; Kittikalayawong Y; Ittiwut C; Prasopsanti K; Sosothikul D; Shotelersuk V; Suphapeetiporn K
    Eur J Haematol; 2017 Dec; 99(6):520-524. PubMed ID: 28888044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A beta3 Asp217-->Val substitution in a patient with variant Glanzmann Thrombasthenia severely affects integrin alphaIIBbeta3 functions.
    D'Andrea G; Bafunno V; Del Vecchio L; Amoriello A; Morabito P; Vecchione G; Grandone E; Margaglione M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):657-62. PubMed ID: 18832906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three novel beta-propeller mutations causing Glanzmann thrombasthenia result in production of normally stable pro-alphaIIb, but variably impaired progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
    Nelson EJ; Li J; Mitchell WB; Chandy M; Srivastava A; Coller BS
    J Thromb Haemost; 2005 Dec; 3(12):2773-83. PubMed ID: 16359515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations.
    Sandrock-Lang K; Oldenburg J; Wiegering V; Halimeh S; Santoso S; Kurnik K; Fischer L; Tsakiris DA; Sigl-Kraetzig M; Brand B; Bührlen M; Kraetzer K; Deeg N; Hund M; Busse E; Kahle A; Zieger B
    Thromb Haemost; 2015 Apr; 113(4):782-91. PubMed ID: 25373348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico analysis of Glanzmann variants of Calf-1 domain of α
    Goguet M; Narwani TJ; Petermann R; Jallu V; de Brevern AG
    Sci Rep; 2017 Aug; 7(1):8001. PubMed ID: 28808266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glanzmann Thrombasthenia in Pakistani Patients: Identification of 7 Novel Pathogenic Variants in the Fibrinogen Receptor αIIbβ3.
    Siddiqi MYJ; Boeckelmann D; Naz A; Imran A; Ahmed S; Najmuddin A; Zieger B
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First description of an IgM monoclonal antibody causing α
    Pillois X; Guy A; Choquet É; James C; Tuffigo M; Viallard JF; Garcia C; Bordet JC; Jandrot-Perrus M; Payrastre B; Fiore M
    J Thromb Haemost; 2019 May; 17(5):795-802. PubMed ID: 30868743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Gln747-->Pro substitution in the IIb subunit is responsible for a moderate IIbbeta3 deficiency in Glanzmann thrombasthenia.
    Tadokoro S; Tomiyama Y; Honda S; Arai M; Yamamoto N; Shiraga M; Kosugi S; Kanakura Y; Kurata Y; Matsuzawa Y
    Blood; 1998 Oct; 92(8):2750-8. PubMed ID: 9763559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia.
    Fang J; Hodivala-Dilke K; Johnson BD; Du LM; Hynes RO; White GC; Wilcox DA
    Blood; 2005 Oct; 106(8):2671-9. PubMed ID: 15972454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A two-amino acid insertion in the Cys146- Cys167 loop of the alphaIIb subunit is associated with a variant of Glanzmann thrombasthenia. Critical role of Asp163 in ligand binding.
    Honda S; Tomiyama Y; Shiraga M; Tadokoro S; Takamatsu J; Saito H; Kurata Y; Matsuzawa Y
    J Clin Invest; 1998 Sep; 102(6):1183-92. PubMed ID: 9739052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunisation against αIIbβ3 and αvβ3 in a type 1 variant of Glanzmann's thrombasthenia caused by a missense mutation Gly540Asp on β3.
    Wihadmadyatami H; Röder L; Berghöfer H; Bein G; Heidinger K; Sachs UJ; Santoso S
    Thromb Haemost; 2016 Aug; 116(2):262-71. PubMed ID: 27098940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linkage disequilibrium amongst ITGA2B and ITGB3 gene variants in patients with Glanzmann thrombasthenia confirms that most disease-causing mutations are recent.
    Pillois X; Nurden AT
    Br J Haematol; 2016 Nov; 175(4):686-695. PubMed ID: 27469266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Frameshift Mutation in the ITGB3 Gene Leading to Glanzmann's Thrombasthenia in a Saudi Arabian Family.
    Alharbi A; Hashmi JA; Alharby E; Albalawi AM; Ramzan K; Basit S
    Hematol Oncol Stem Cell Ther; 2022 Mar; 15(1):21-26. PubMed ID: 33600779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Ser162-->Leu mutation within glycoprotein (GP) IIIa (integrin beta3) results in an unstable alphaIIbbeta3 complex that retains partial function in a novel form of type II Glanzmann thrombasthenia.
    Jackson DE; White MM; Jennings LK; Newman PJ
    Thromb Haemost; 1998 Jul; 80(1):42-8. PubMed ID: 9684783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular dynamics analysis of a novel β3 Pro189Ser mutation in a patient with glanzmann thrombasthenia differentially affecting αIIbβ3 and αvβ3 expression.
    Laguerre M; Sabi E; Daly M; Stockley J; Nurden P; Pillois X; Nurden AT
    PLoS One; 2013; 8(11):e78683. PubMed ID: 24236036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the amino acid requirement for a normal alphaIIbbeta3 maturation at alphaIIbGlu324 commonly mutated in Glanzmann thrombasthenia.
    Milet-Marsal S; Breillat C; Peyruchaud O; Nurden P; Combrié R; Nurden AT; Bourre F
    Thromb Haemost; 2002 Oct; 88(4):655-62. PubMed ID: 12362239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glanzmann thrombasthenia: state of the art and future directions.
    Nurden AT; Pillois X; Wilcox DA
    Semin Thromb Hemost; 2013 Sep; 39(6):642-55. PubMed ID: 23929305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.
    Ruiz C; Liu CY; Sun QH; Sigaud-Fiks M; Fressinaud E; Muller JY; Nurden P; Nurden AT; Newman PJ; Valentin N
    Blood; 2001 Oct; 98(8):2432-41. PubMed ID: 11588040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SINE-VNTR-Alu retrotransposon insertion as a novel mutational event underlying Glanzmann thrombasthenia.
    Zhang J; Tang J; Li G; Li N; Wang J; Yao R; Yu T
    J Thromb Haemost; 2023 Dec; 21(12):3597-3607. PubMed ID: 37604334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular dynamics simulations corroborate recombinant expression studies carried out on three αIIb β-propeller mutations reported in Indian Glanzmann thrombasthenia patients.
    Chandrasekaran FP; Vishal A; Arora U; Kumar S U; George C PD; Nelson EJR
    J Cell Biochem; 2023 Jul; 124(7):989-1001. PubMed ID: 37210732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.